BIO vs INGN · rev $651.0M vs rev $180.2M
BIO (BIO) versus Inogen Inc (INGN) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Inogen Inc (INGN) is a medical devices company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported INGN revenue for 2026-06-30 was $180.2M. Net income was -$12.2M. INGN currently screens at market cap $173.5M.
BIO currently screens at market cap $0. INGN currently screens at market cap $173.5M.
Not investment advice. Open the BIO and INGN stock pages for the full models.
Not investment advice.